Reader survey – Your opinion matters

As NeuroSens readership continues to grow, we are constantly striving to keep our content relevant and interesting. You can help us by completing this very quick survey. It’s only four questions and your responses will be invaluable in our publication planning efforts.

	3 (high)	2 (moderate)	1 (low)
Multiple sclerosis	Multiple sclerosis 3 (high)	Multiple sclerosis 2 (moderate)	Multiple sclerosis 1 (low)
Other demyelinating disorders (e.g. NMOSD, MOGAD)	Other demyelinating disorders (e.g. NMOSD, MOGAD) 3 (high)	Other demyelinating disorders (e.g. NMOSD, MOGAD) 2 (moderate)	Other demyelinating disorders (e.g. NMOSD, MOGAD) 1 (low)
Parkinson disease	Parkinson disease 3 (high)	Parkinson disease 2 (moderate)	Parkinson disease 1 (low)
Alzheimer disease and other dementias	Alzheimer disease and other dementias 3 (high)	Alzheimer disease and other dementias 2 (moderate)	Alzheimer disease and other dementias 1 (low)
Epilepsy and other seizure disorders	Epilepsy and other seizure disorders 3 (high)	Epilepsy and other seizure disorders 2 (moderate)	Epilepsy and other seizure disorders 1 (low)
Migraine and other headache disorders	Migraine and other headache disorders 3 (high)	Migraine and other headache disorders 2 (moderate)	Migraine and other headache disorders 1 (low)
Narcolepsy and other sleep disorders	Narcolepsy and other sleep disorders 3 (high)	Narcolepsy and other sleep disorders 2 (moderate)	Narcolepsy and other sleep disorders 1 (low)
Myasthenia gravis	Myasthenia gravis 3 (high)	Myasthenia gravis 2 (moderate)	Myasthenia gravis 1 (low)
Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis 3 (high)	Amyotrophic lateral sclerosis 2 (moderate)	Amyotrophic lateral sclerosis 1 (low)
Spinal muscular atrophy (SMA)	Spinal muscular atrophy (SMA) 3 (high)	Spinal muscular atrophy (SMA) 2 (moderate)	Spinal muscular atrophy (SMA) 1 (low)
Stroke	Stroke 3 (high)	Stroke 2 (moderate)	Stroke 1 (low)
Glioblastoma multiforme and other brain tumours	Glioblastoma multiforme and other brain tumours 3 (high)	Glioblastoma multiforme and other brain tumours 2 (moderate)	Glioblastoma multiforme and other brain tumours 1 (low)

3 (high)

2 (moderate)

1 (low)

Multiple sclerosis

Multiple sclerosis 3 (high)

Multiple sclerosis 2 (moderate)

Multiple sclerosis 1 (low)

Other demyelinating disorders (e.g. NMOSD, MOGAD)

Other demyelinating disorders (e.g. NMOSD, MOGAD) 3 (high)

Other demyelinating disorders (e.g. NMOSD, MOGAD) 2 (moderate)

Other demyelinating disorders (e.g. NMOSD, MOGAD) 1 (low)

Parkinson disease

Parkinson disease 3 (high)

Parkinson disease 2 (moderate)

Parkinson disease 1 (low)

Alzheimer disease and other dementias

Alzheimer disease and other dementias 3 (high)

Alzheimer disease and other dementias 2 (moderate)

Alzheimer disease and other dementias 1 (low)

Epilepsy and other seizure disorders

Epilepsy and other seizure disorders 3 (high)

Epilepsy and other seizure disorders 2 (moderate)

Epilepsy and other seizure disorders 1 (low)

Migraine and other headache disorders

Migraine and other headache disorders 3 (high)

Migraine and other headache disorders 2 (moderate)

Migraine and other headache disorders 1 (low)

Narcolepsy and other sleep disorders

Narcolepsy and other sleep disorders 3 (high)

Narcolepsy and other sleep disorders 2 (moderate)

Narcolepsy and other sleep disorders 1 (low)

Myasthenia gravis

Myasthenia gravis 3 (high)

Myasthenia gravis 2 (moderate)

Myasthenia gravis 1 (low)

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis 3 (high)

Amyotrophic lateral sclerosis 2 (moderate)

Amyotrophic lateral sclerosis 1 (low)

Spinal muscular atrophy (SMA)

Spinal muscular atrophy (SMA) 3 (high)

Spinal muscular atrophy (SMA) 2 (moderate)

Spinal muscular atrophy (SMA) 1 (low)

Stroke

Stroke 3 (high)

Stroke 2 (moderate)

Stroke 1 (low)

Glioblastoma multiforme and other brain tumours

Glioblastoma multiforme and other brain tumours 3 (high)

Glioblastoma multiforme and other brain tumours 2 (moderate)

Glioblastoma multiforme and other brain tumours 1 (low)

	3 (high)	2 (moderate)	1 (low)
World Congress of Neurology	World Congress of Neurology 3 (high)	World Congress of Neurology 2 (moderate)	World Congress of Neurology 1 (low)
American Academy of Neurology (AAN)	American Academy of Neurology (AAN) 3 (high)	American Academy of Neurology (AAN) 2 (moderate)	American Academy of Neurology (AAN) 1 (low)
European Academy of Neurology (EAN)	European Academy of Neurology (EAN) 3 (high)	European Academy of Neurology (EAN) 2 (moderate)	European Academy of Neurology (EAN) 1 (low)
Canadian Neurological Sciences Federation (CNSF)	Canadian Neurological Sciences Federation (CNSF) 3 (high)	Canadian Neurological Sciences Federation (CNSF) 2 (moderate)	Canadian Neurological Sciences Federation (CNSF) 1 (low)
European Committee for Treatment and Research in MS (ECTRIMS)	European Committee for Treatment and Research in MS (ECTRIMS) 3 (high)	European Committee for Treatment and Research in MS (ECTRIMS) 2 (moderate)	European Committee for Treatment and Research in MS (ECTRIMS) 1 (low)
Americas Committee for Treatment and Research in MS (ACTRIMS)	Americas Committee for Treatment and Research in MS (ACTRIMS) 3 (high)	Americas Committee for Treatment and Research in MS (ACTRIMS) 2 (moderate)	Americas Committee for Treatment and Research in MS (ACTRIMS) 1 (low)
ACTRIMS Forum	ACTRIMS Forum 3 (high)	ACTRIMS Forum 2 (moderate)	ACTRIMS Forum 1 (low)
European Charcot Foundation	European Charcot Foundation 3 (high)	European Charcot Foundation 2 (moderate)	European Charcot Foundation 1 (low)
American Epilepsy Society	American Epilepsy Society 3 (high)	American Epilepsy Society 2 (moderate)	American Epilepsy Society 1 (low)
International League Against Epilepsy (ILAE)	International League Against Epilepsy (ILAE) 3 (high)	International League Against Epilepsy (ILAE) 2 (moderate)	International League Against Epilepsy (ILAE) 1 (low)
Alzheimer’s Association International Conference (AAIC)	Alzheimer’s Association International Conference (AAIC) 3 (high)	Alzheimer’s Association International Conference (AAIC) 2 (moderate)	Alzheimer’s Association International Conference (AAIC) 1 (low)
AD/PD	AD/PD 3 (high)	AD/PD 2 (moderate)	AD/PD 1 (low)
American Headache Society	American Headache Society 3 (high)	American Headache Society 2 (moderate)	American Headache Society 1 (low)
Myasthenia Gravis Foundation of America (MGFA)	Myasthenia Gravis Foundation of America (MGFA) 3 (high)	Myasthenia Gravis Foundation of America (MGFA) 2 (moderate)	Myasthenia Gravis Foundation of America (MGFA) 1 (low)

3 (high)

2 (moderate)

1 (low)

World Congress of Neurology

World Congress of Neurology 3 (high)

World Congress of Neurology 2 (moderate)

World Congress of Neurology 1 (low)

American Academy of Neurology (AAN)

American Academy of Neurology (AAN) 3 (high)

American Academy of Neurology (AAN) 2 (moderate)

American Academy of Neurology (AAN) 1 (low)

European Academy of Neurology (EAN)

European Academy of Neurology (EAN) 3 (high)

European Academy of Neurology (EAN) 2 (moderate)

European Academy of Neurology (EAN) 1 (low)

Canadian Neurological Sciences Federation (CNSF)

Canadian Neurological Sciences Federation (CNSF) 3 (high)

Canadian Neurological Sciences Federation (CNSF) 2 (moderate)

Canadian Neurological Sciences Federation (CNSF) 1 (low)

European Committee for Treatment and Research in MS (ECTRIMS)

European Committee for Treatment and Research in MS (ECTRIMS) 3 (high)

European Committee for Treatment and Research in MS (ECTRIMS) 2 (moderate)

European Committee for Treatment and Research in MS (ECTRIMS) 1 (low)

Americas Committee for Treatment and Research in MS (ACTRIMS)

Americas Committee for Treatment and Research in MS (ACTRIMS) 3 (high)

Americas Committee for Treatment and Research in MS (ACTRIMS) 2 (moderate)

Americas Committee for Treatment and Research in MS (ACTRIMS) 1 (low)

ACTRIMS Forum

ACTRIMS Forum 3 (high)

ACTRIMS Forum 2 (moderate)

ACTRIMS Forum 1 (low)

European Charcot Foundation

European Charcot Foundation 3 (high)

European Charcot Foundation 2 (moderate)

European Charcot Foundation 1 (low)

American Epilepsy Society

American Epilepsy Society 3 (high)

American Epilepsy Society 2 (moderate)

American Epilepsy Society 1 (low)

International League Against Epilepsy (ILAE)

International League Against Epilepsy (ILAE) 3 (high)

International League Against Epilepsy (ILAE) 2 (moderate)

International League Against Epilepsy (ILAE) 1 (low)

Alzheimer’s Association International Conference (AAIC)

Alzheimer’s Association International Conference (AAIC) 3 (high)

Alzheimer’s Association International Conference (AAIC) 2 (moderate)

Alzheimer’s Association International Conference (AAIC) 1 (low)

AD/PD

AD/PD 3 (high)

AD/PD 2 (moderate)

AD/PD 1 (low)

American Headache Society

American Headache Society 3 (high)

American Headache Society 2 (moderate)

American Headache Society 1 (low)

Myasthenia Gravis Foundation of America (MGFA)

Myasthenia Gravis Foundation of America (MGFA) 3 (high)

Myasthenia Gravis Foundation of America (MGFA) 2 (moderate)

Myasthenia Gravis Foundation of America (MGFA) 1 (low)

	1 (most preferred)	2	3	4	5	6	7	8	9 (least preferred)
Shorter items on new research	Shorter items on new research 1 (most preferred)	Shorter items on new research 2	Shorter items on new research 3	Shorter items on new research 4	Shorter items on new research 5	Shorter items on new research 6	Shorter items on new research 7	Shorter items on new research 8	Shorter items on new research 9 (least preferred)
Longer single-topic reviews	Longer single-topic reviews 1 (most preferred)	Longer single-topic reviews 2	Longer single-topic reviews 3	Longer single-topic reviews 4	Longer single-topic reviews 5	Longer single-topic reviews 6	Longer single-topic reviews 7	Longer single-topic reviews 8	Longer single-topic reviews 9 (least preferred)
Daily highlights from congresses	Daily highlights from congresses 1 (most preferred)	Daily highlights from congresses 2	Daily highlights from congresses 3	Daily highlights from congresses 4	Daily highlights from congresses 5	Daily highlights from congresses 6	Daily highlights from congresses 7	Daily highlights from congresses 8	Daily highlights from congresses 9 (least preferred)
Post-congress summaries	Post-congress summaries 1 (most preferred)	Post-congress summaries 2	Post-congress summaries 3	Post-congress summaries 4	Post-congress summaries 5	Post-congress summaries 6	Post-congress summaries 7	Post-congress summaries 8	Post-congress summaries 9 (least preferred)
Mini slide deck resources	Mini slide deck resources 1 (most preferred)	Mini slide deck resources 2	Mini slide deck resources 3	Mini slide deck resources 4	Mini slide deck resources 5	Mini slide deck resources 6	Mini slide deck resources 7	Mini slide deck resources 8	Mini slide deck resources 9 (least preferred)
Webinars (e.g. ECTRIMS, ACTRIMS Forum)	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 1 (most preferred)	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 2	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 3	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 4	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 5	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 6	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 7	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 8	Webinars (e.g. ECTRIMS, ACTRIMS Forum) 9 (least preferred)
Clinical case discussions	Clinical case discussions 1 (most preferred)	Clinical case discussions 2	Clinical case discussions 3	Clinical case discussions 4	Clinical case discussions 5	Clinical case discussions 6	Clinical case discussions 7	Clinical case discussions 8	Clinical case discussions 9 (least preferred)
Interviews with experts (audio or video)	Interviews with experts (audio or video) 1 (most preferred)	Interviews with experts (audio or video) 2	Interviews with experts (audio or video) 3	Interviews with experts (audio or video) 4	Interviews with experts (audio or video) 5	Interviews with experts (audio or video) 6	Interviews with experts (audio or video) 7	Interviews with experts (audio or video) 8	Interviews with experts (audio or video) 9 (least preferred)
Key poster announcements at congresses (poster picks)	Key poster announcements at congresses (poster picks) 1 (most preferred)	Key poster announcements at congresses (poster picks) 2	Key poster announcements at congresses (poster picks) 3	Key poster announcements at congresses (poster picks) 4	Key poster announcements at congresses (poster picks) 5	Key poster announcements at congresses (poster picks) 6	Key poster announcements at congresses (poster picks) 7	Key poster announcements at congresses (poster picks) 8	Key poster announcements at congresses (poster picks) 9 (least preferred)

1 (most preferred)

9 (least preferred)

Shorter items on new research

Shorter items on new research 1 (most preferred)

Shorter items on new research 2

Shorter items on new research 3

Shorter items on new research 4

Shorter items on new research 5

Shorter items on new research 6

Shorter items on new research 7

Shorter items on new research 8

Shorter items on new research 9 (least preferred)

Longer single-topic reviews

Longer single-topic reviews 1 (most preferred)

Longer single-topic reviews 2

Longer single-topic reviews 3

Longer single-topic reviews 4

Longer single-topic reviews 5

Longer single-topic reviews 6

Longer single-topic reviews 7

Longer single-topic reviews 8

Longer single-topic reviews 9 (least preferred)

Daily highlights from congresses

Daily highlights from congresses 1 (most preferred)

Daily highlights from congresses 2

Daily highlights from congresses 3

Daily highlights from congresses 4

Daily highlights from congresses 5

Daily highlights from congresses 6

Daily highlights from congresses 7

Daily highlights from congresses 8

Daily highlights from congresses 9 (least preferred)

Post-congress summaries

Post-congress summaries 1 (most preferred)

Post-congress summaries 2

Post-congress summaries 3

Post-congress summaries 4

Post-congress summaries 5

Post-congress summaries 6

Post-congress summaries 7

Post-congress summaries 8

Post-congress summaries 9 (least preferred)

Mini slide deck resources

Mini slide deck resources 1 (most preferred)

Mini slide deck resources 2

Mini slide deck resources 3

Mini slide deck resources 4

Mini slide deck resources 5

Mini slide deck resources 6

Mini slide deck resources 7

Mini slide deck resources 8

Mini slide deck resources 9 (least preferred)

Webinars (e.g. ECTRIMS, ACTRIMS Forum)

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 1 (most preferred)

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 2

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 3

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 4

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 5

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 6

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 7

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 8

Webinars (e.g. ECTRIMS, ACTRIMS Forum) 9 (least preferred)

Clinical case discussions

Clinical case discussions 1 (most preferred)

Clinical case discussions 2

Clinical case discussions 3

Clinical case discussions 4

Clinical case discussions 5

Clinical case discussions 6

Clinical case discussions 7

Clinical case discussions 8

Clinical case discussions 9 (least preferred)

Interviews with experts (audio or video)

Interviews with experts (audio or video) 1 (most preferred)

Interviews with experts (audio or video) 2

Interviews with experts (audio or video) 3

Interviews with experts (audio or video) 4

Interviews with experts (audio or video) 5

Interviews with experts (audio or video) 6

Interviews with experts (audio or video) 7

Interviews with experts (audio or video) 8

Interviews with experts (audio or video) 9 (least preferred)

Key poster announcements at congresses (poster picks)

Key poster announcements at congresses (poster picks) 1 (most preferred)

Key poster announcements at congresses (poster picks) 2

Key poster announcements at congresses (poster picks) 3

Key poster announcements at congresses (poster picks) 4

Key poster announcements at congresses (poster picks) 5

Key poster announcements at congresses (poster picks) 6

Key poster announcements at congresses (poster picks) 7

Key poster announcements at congresses (poster picks) 8

Key poster announcements at congresses (poster picks) 9 (least preferred)

Reader survey – Your opinion matters

Question Title

* 1. Rate your level of interest in the following areas of neurology? (3=high; 2=moderate; 1=low)

Question Title

* 2. Rate your level of interest in the following meetings? (3=high; 2=moderate; 1=low)

Question Title

* 3. Please rank your preferences in the following formats on NeuroSens? (1=most preferred; 9=least preferred)

Question Title

* 4. Additional comments:

Question Title

* 5. I am a: